Conference Archive
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Issues Complete Response Letter for Spinocerebellar Ataxia Agent Troriluzole
2
New Phase 3 Study to Evaluate Remibrutinib in Generalized Myasthenia Gravis Treatment
3
Early-Stage Study to Test CD19 CAR T-Cell Therapy YTB323 in Myasthenia Gravis
4
FDA Approves Doxecitine and Doxribtimine Combination Therapy as First Treatment for Thymidine Kinase 2 Deficiency
5
